SEC Form 25-NSE filed by Iris Acquisition Corp

3/5/25 9:39:09 AM ET

$IRAA

Blank Checks

Finance

Get the next $IRAA alert in real time by email

NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.

UNITED STATES

OMB APPROVAL

OMB Number:		3235-0080
Expires:	March 31, 2018
Estimated average burden
hours per response:		1.7

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 25

NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION
UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission File Number

333-252413

Issuer:	Iris Acquisition Corp
Exchange:	Nasdaq Stock Market LLC

(Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)

Address:	2064 Christie Street
	Fullerton	CALIFORNIA	92833
Telephone number:				323-992-7676

(Address, including zip code, and telephone number, including area code, of Issuer's principal executive offices)

Class A Common Stock, Unit, Warrant

(Description of class of securities)

Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:

17 CFR 240.12d2-2(a)(1)

17 CFR 240.12d2-2(a)(2)

17 CFR 240.12d2-2(a)(3)

17 CFR 240.12d2-2(a)(4)

Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange. ¹

Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with its rules of the Exchange and the requirements of 17 CFR 240.12d-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.

Pursuant to the requirements fo the Securities Exchange Act of 1934, Nasdaq Stock Market LLC certifies that it has reasonable grounds to believe that it meets all of the requirements for filing the Form 25 and has caused this notification to be signed on its behalf by the undersigned duly authorized person.

2025-03-05	By	Aravind Menon		Hearings Advisor
Date		Name		Title

¹	Form 25 and attached Notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Get the next $IRAA alert in real time by email

SEC Form 25-NSE filed by Iris Acquisition Corp

3/5/25 9:39:09 AM ET

$IRAA

Blank Checks

Finance

Get the next $IRAA alert in real time by email

NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.

UNITED STATES

OMB APPROVAL

OMB Number:		3235-0080
Expires:	March 31, 2018
Estimated average burden
hours per response:		1.7

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 25

NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION
UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission File Number

333-252413

Issuer:	Iris Acquisition Corp
Exchange:	Nasdaq Stock Market LLC

(Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)

Address:	2064 Christie Street
	Fullerton	CALIFORNIA	92833
Telephone number:				323-992-7676

(Address, including zip code, and telephone number, including area code, of Issuer's principal executive offices)

Class A Common Stock, Unit, Warrant

(Description of class of securities)

Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:

17 CFR 240.12d2-2(a)(1)

17 CFR 240.12d2-2(a)(2)

17 CFR 240.12d2-2(a)(3)

17 CFR 240.12d2-2(a)(4)

Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange. ¹

2025-03-05	By	Aravind Menon		Hearings Advisor
Date		Name		Title

¹	Form 25 and attached Notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Get the next $IRAA alert in real time by email

SEC Form 25-NSE filed by Iris Acquisition Corp

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for
$IRAA

SEC Form 25-NSE filed by Iris Acquisition Corp

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for
$IRAA

$IRAA
Press Releases

Legion Partners Issues Letter to The Chefs' Warehouse, Inc. Shareholders Calling for Urgently Needed Board Change

Program CD47, provided the CMC service by GenScript ProBio to InnobationBio, will further be advanced by the joint venture between Liminatus Pharma LLC and Iris Acquisition Corp

Liminatus Pharma LLC and Iris Acquisition Corp to combine to incorporate and accelerate much-needed cancer treatments

$IRAA
Insider Trading

Saba Capital Management, L.P. sold $8,781,435 worth of shares (853,395 units at $10.29) (SEC Form 4)

New insider Moore Capital Management, Lp claimed ownership of 100,000 shares (SEC Form 3)

SEC Form 3: New insider Saba Capital Management, L.P. claimed ownership of 853,395 shares

$IRAA
SEC Filings

SEC Form 15-12G filed by Iris Acquisition Corp

SEC Form 10-K filed by Iris Acquisition Corp

SEC Form NT 10-K filed by Iris Acquisition Corp

$IRAA
Large Ownership Changes

SEC Form SC 13G/A filed by Iris Acquisition Corp (Amendment)

SEC Form SC 13G/A filed by Iris Acquisition Corp (Amendment)

SEC Form SC 13G/A filed by Iris Acquisition Corp (Amendment)

SEC Form 25-NSE filed by Iris Acquisition Corp

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for $IRAA

SEC Form 25-NSE filed by Iris Acquisition Corp

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for $IRAA

$IRAA Press Releases

Legion Partners Issues Letter to The Chefs' Warehouse, Inc. Shareholders Calling for Urgently Needed Board Change

Program CD47, provided the CMC service by GenScript ProBio to InnobationBio, will further be advanced by the joint venture between Liminatus Pharma LLC and Iris Acquisition Corp

Liminatus Pharma LLC and Iris Acquisition Corp to combine to incorporate and accelerate much-needed cancer treatments

$IRAA Insider Trading

Saba Capital Management, L.P. sold $8,781,435 worth of shares (853,395 units at $10.29) (SEC Form 4)

New insider Moore Capital Management, Lp claimed ownership of 100,000 shares (SEC Form 3)

SEC Form 3: New insider Saba Capital Management, L.P. claimed ownership of 853,395 shares

$IRAA SEC Filings

SEC Form 15-12G filed by Iris Acquisition Corp

SEC Form 10-K filed by Iris Acquisition Corp

SEC Form NT 10-K filed by Iris Acquisition Corp

$IRAA Large Ownership Changes

SEC Form SC 13G/A filed by Iris Acquisition Corp (Amendment)

SEC Form SC 13G/A filed by Iris Acquisition Corp (Amendment)

SEC Form SC 13G/A filed by Iris Acquisition Corp (Amendment)

Recent Analyst Ratings for
$IRAA

Recent Analyst Ratings for
$IRAA

$IRAA
Press Releases

$IRAA
Insider Trading

$IRAA
SEC Filings

$IRAA
Large Ownership Changes